Brian Lee Claggett

86PUBLICATIONS
403CO-AUTHORS
Behavioural epidemiologyMolecular targetsRespiratory diseasesReinforcement learningCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (86)

|Apr 09, 2026
Lifetime benefits of finerenone on cardiorenal morbidity and mortality in chronic kidney disease and type 2 diabetes: a pooled analysis of FIDELIO-DKD and FIGARO-DKD trials.

John W Ostrominski, Brendon L Neuen, Brian L Claggett

|Mar 28, 2026
Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men.

Daniel Ezzat, Diana M Lopez, Brian L Claggett

|Mar 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy Questionnaire.

Yasuhiro Hamatani, Alexander Peikert, Brian L Claggett

|Mar 02, 2026
Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial.

Alberto Foà, Muthiah Vaduganathan, Brian L Claggett

|Mar 02, 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.

Yasuhiro Hamatani, Brian L Claggett, Ian J Kulac

|Mar 02, 2026
Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trials.

Alberto Foà, Henri Lu, Muthiah Vaduganathan

Pageof 15

Frequent Collaborators

59 joint publications

Scott D Solomon

32 joint publications

Muthiah Vaduganathan

31 joint publications

John McMurray

24 joint publications

Akshay S Desai